Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Aditya Birla Sun Life AMC Limited · Direct Plan · Growth
Fund overview
1% on or before 30D, Nil after 30D
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,199 | +199 |
| 3 Years | ₹1,000 | ₹1,722 | +722 |
| 5 Years | ₹1,000 | ₹2,474 | +1,474 |
Calculated using the fund's annualised return since inception (19.9% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
39 securitiesTop 10 holdings make up 51.2% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 9.28% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 8.61% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 6.44% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 6.38% |
| Aurobindo Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.52% |
| SAI Life Sciences Ltd | Pharmaceuticals & Biotechnology | Small Cap | 4.49% |
| Ajanta Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.35% |
| Mankind Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 3.62% |
| Dr. Lal Pathlabs Ltd | Healthcare Services | Small Cap | 3.51% |
| Abbott India Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 3.26% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹1,078 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹1,055 Cr
Exit load, stamp duty & tax
10-Jul-19
1% on or before 30D, Nil after 30D
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 15.32% |
| Beta | 0.94 |
| Sharpe Ratio | 3.06 |
| Sortino Ratio | 0.32 |
| Treynor Ratio | 0.50 |
| Jensen's Alpha | 4.40 |
| Information Ratio | 0.24 |
| R-Squared | 97.46% |
| Max Drawdown | -3.76% |
| Upside Capture | 100.72% |
| Downside Capture | 76.64% |
Fund management
Scheme Details
Investment objective
Investment Objective Of The Scheme Is To Provide Long Term Capital Appreciation By Investing In Equity & Equity Related Instruments Of The Companies In The Pharmaceuticals, Healthcare And Allied Sectors In India.The Scheme Does Not Guarantee/Indicate Any Returns. There Can Be No Assurance That The Schemes Objectives Will Be Achieved.
Fund house
Aditya Birla Sun Life AMC Limited
Frequently asked questions
What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The NAV of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is ₹37.44 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The expense ratio charged by Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is 1.07%.
What is the Min. SIP of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The minimum SIP investment in Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is ₹100 per month.
What is the Min. Lumpsum of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The minimum lumpsum investment in Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is ₹1,000.
What is the Exit Load of Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth?
The exit load for Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth is: 1% on or before 30D, Nil after 30D
.svg){kind=small}